82 related articles for article (PubMed ID: 11961896)
1. [Transdermal therapeutic systems].
Makó S; Stampf G
Acta Pharm Hung; 2001 Oct; 71(3):293-9. PubMed ID: 11961896
[TBL] [Abstract][Full Text] [Related]
2. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
3. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
4. In vitro release study of transdermal delivery systems of progesterone.
Valenta C; Biebel R
Drug Dev Ind Pharm; 1998 Feb; 24(2):187-91. PubMed ID: 15605451
[TBL] [Abstract][Full Text] [Related]
5. [Transdermal therapeutic systems for drug administration].
Hupfeld S; Gravem H
Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
[TBL] [Abstract][Full Text] [Related]
6. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
Henzl MR; Loomba PK
J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pharmacodynamic variables following oral versus transdermal administration of atenolol to healthy cats.
Macgregor JM; Rush JE; Rozanski EA; Boothe DM; Belmonte AA; Freeman LM
Am J Vet Res; 2008 Jan; 69(1):39-44. PubMed ID: 18167085
[TBL] [Abstract][Full Text] [Related]
10. Polyoxyethylene fatty acid esters as potential promotors of transdermal absorption for morphine hydrochloride and sulphate.
Samczewska G; Piechota-Urbańska M; Kołodziejska J
Polim Med; 2006; 36(2):17-32. PubMed ID: 17022153
[TBL] [Abstract][Full Text] [Related]
11. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
[TBL] [Abstract][Full Text] [Related]
12. Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients.
Solassol I; Caumette L; Bressolle F; Garcia F; Thézenas S; Astre C; Culine S; Coulouma R; Pinguet F
Oncol Rep; 2005 Oct; 14(4):1029-36. PubMed ID: 16142368
[TBL] [Abstract][Full Text] [Related]
13. Painless drug delivery through microneedle-based transdermal patches featuring active infusion.
Roxhed N; Samel B; Nordquist L; Griss P; Stemme G
IEEE Trans Biomed Eng; 2008 Mar; 55(3):1063-71. PubMed ID: 18334398
[TBL] [Abstract][Full Text] [Related]
14. [Transdermal therapeutic systems (TTS)].
Dittgen M
Med Monatsschr Pharm; 1998 Dec; 21(12):366-77. PubMed ID: 9868897
[No Abstract] [Full Text] [Related]
15. Application of sucrose fatty acid esters in transdermal therapeutic systems.
Csóka G; Marton S; Zelko R; Otomo N; Antal I
Eur J Pharm Biopharm; 2007 Feb; 65(2):233-7. PubMed ID: 16963242
[TBL] [Abstract][Full Text] [Related]
16. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance.
Prasad Verma PR; Chandak AR
Acta Pharm; 2009 Jun; 59(2):171-86. PubMed ID: 19564142
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery.
Alberti I; Grenier A; Kraus H; Carrara DN
Expert Opin Drug Deliv; 2005 Sep; 2(5):935-50. PubMed ID: 16296788
[TBL] [Abstract][Full Text] [Related]
18. Validated GC-MS analysis for the determination of residual fentanyl in applied Durogesic reservoir and Durogesic D-Trans matrix transdermal fentanyl patches.
Van Nimmen NF; Veulemans HA
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):264-72. PubMed ID: 17030157
[TBL] [Abstract][Full Text] [Related]
19. Transdermal nicotine patch for postoperative pain management: a pilot dose-ranging study.
Hong D; Conell-Price J; Cheng S; Flood P
Anesth Analg; 2008 Sep; 107(3):1005-10. PubMed ID: 18713921
[TBL] [Abstract][Full Text] [Related]
20. The renin-angiotensin system: a therapeutic target in atrial fibrillation.
Patlolla V; Alsheikh-Ali AA; Al-Ahmad AM
Pacing Clin Electrophysiol; 2006 Sep; 29(9):1006-12. PubMed ID: 16981926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
